Should I buy or sell Ambu A/S stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambu A/S in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMBBY shares. View AMBBY analyst ratings or view top-rated stocks .

How have AMBBY shares performed in 2024?

Ambu A/S's stock was trading at $15.30 at the beginning of 2024. Since then, AMBBY stock has increased by 4.0% and is now trading at $15.9183. View the best growth stocks for 2024 here .

How do I buy shares of Ambu A/S?

Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:AMBBY

Ambu A/S (AMBBY) Stock Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)

Free AMBBY Stock Alerts

$15.92

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $15.92
▼
$15.92
50-Day Range: $15.30
▼
$17.48
52-Week Range: $9.45
▼
$17.48

Volume: 1 shs
Average Volume: 296 shs
Market Capitalization: $3.74 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Get Ambu A/S alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Ambu A/S Stock (OTCMKTS:AMBBY)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

AMBBY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AMBBY Stock News Headlines

April 11, 2024 | americanbankingnews.com

Ambu A/S (OTCMKTS:AMBBY) Stock Price Up 2%

February 9, 2024 | finance.yahoo.com

Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities

April 19, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

February 6, 2024 | finance.yahoo.com

GRANT OF PERFORMANCE SHARE UNITS

February 4, 2024 | msn.com

Why Anisa Percival's breakout scoring night bodes well for the Ames girls basketball team

February 4, 2024 | morningstar.com

Ambu A/S Class B AMBU B

January 31, 2024 | realmoney.thestreet.com

Ambu price target raised by DKK 5 at JPMorgan

January 30, 2024 | finance.yahoo.com

INTERIM REPORT FOR Q1 2023/24

April 19, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

January 16, 2024 | realmoney.thestreet.com

Handelsbanken gets more bearish on Ambu, downgrades shares

December 15, 2023 | uk.investing.com

Ambu A/S (0MJF)

December 13, 2023 | morningstar.com

Ambu A/S Class B AMBFF

November 8, 2023 | finance.yahoo.com

AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR

November 8, 2023 | finance.yahoo.com

ANNUAL REPORT 2022/23 (EARNINGS RELEASE)

October 11, 2023 | finance.yahoo.com

AMBU APPOINTS NEW CHIEF FINANCIAL OFFICER

October 9, 2023 | finance.yahoo.com

AMBU ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR THE FISCAL YEAR 2022/23

September 29, 2023 | bbc.co.uk

A 360° King's coronation view inside Westminster Abbey

September 29, 2023 | finance.yahoo.com

AMBU FINANCIAL CALENDAR FOR 2023/24

August 31, 2023 | finance.yahoo.com

INTERIM REPORT FOR Q3 2022/23

August 30, 2023 | markets.businessinsider.com

Ambu A-S Bearer and-or registered B is about to announce earnings — here's what Wall Street expects

August 16, 2023 | forbes.com

Earning A Master’s In Homeland Security: What To Know

July 28, 2023 | finance.yahoo.com

Grant of Performance Share Units and reporting of transactions in accordance with Article 19 of the Market Abuse Regulation

July 25, 2023 | nbcnews.com

In one of the world's deadliest cities, a musician's idea pays off

July 22, 2023 | health.usnews.com

Dr. Abbey S. Hawkins

July 10, 2023 | finance.yahoo.com

AMBU UPGRADES FULL-YEAR 2022/23 EARNINGS EXPECTATIONS ON THE BACK OF PRELIMINARY Q3 2022/23 RESULTS

May 19, 2023 | usatoday.com

Felony charges, no trial: How a traffic stop upended her life for three years

May 3, 2023 | finance.yahoo.com

INTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEAR

See More Headlines

Receive AMBBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:AMBBY
Previous Symbol: OTCMKTS:AMBBY
CUSIP: N/A
CIK: N/A
Web: www.ambu.com
Phone: (457) 225-2000
Fax: N/A
Employees: 4,600
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 234,970,000
Free Float: N/A
Market Cap: $3.74 billion
Optionable: Not Optionable
Beta: N/A

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Ms. Britt Meelby Jensen (Age 51)
Chief Executive Officer
Comp: $1.93M
Holger Hesse
Founder
Mr. Henrik Skak Bender
Executive VP & CFO
Henrik Birk (Age 50)
Chief Operations Officer
Mr. Finn Mohring (Age 59)
Chief Technology Officer
Mr. Nicolai Thomsen
Director of Investor Relations & Strategic Financial Planning
Mikkel Trier Wagner
Director of Corporate Communications
Rummana Hasan
Chief Marketing Officer
Mr. Thomas Lykke Henriksen (Age 51)
Head of HR Systems
Comp: $10.29k
Mr. Måns Barsne
Executive VP of Global Innovation & Chief Innovation Officer

Key Competitors

View All Competitors

AMBBY Stock Analysis - Frequently Asked Questions

Should I buy or sell Ambu A/S stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambu A/S in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMBBY shares.
View AMBBY analyst ratings or view top-rated stocks.
How have AMBBY shares performed in 2024?: Ambu A/S's stock was trading at $15.30 at the beginning of 2024. Since then, AMBBY stock has increased by 4.0% and is now trading at $15.9183.
View the best growth stocks for 2024 here.
How do I buy shares of Ambu A/S?: Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AMBBY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial